myotonic muscular dystrophy - Viral Trends
CLEVELAND, Ohio — Stand-up comedian and actor Gilbert Gottfried, who died this week at 67, lived for years with the rare genetic muscle disorder myotonic dystrophy type 2, a common form of muscular ... News Medical: Next-generation sequencing provides novel insights into the mechanisms underlying autism and myotonic muscular dystrophy Next-generation sequencing provides novel insights into the mechanisms underlying autism and myotonic muscular dystrophy India, April 5 -- Myotonic dystrophy type 1 (DM1) is the leading form of muscular dystrophy that appears in adulthood. While it is best known for causing progressive muscle weakness and loss, the ...
Understanding the Context
Yahoo: Gilbert Gottfried Died From Muscular Dystrophy Complications—Here’s What to Know About the Illness Gilbert Gottfried Died From Muscular Dystrophy Complications—Here’s What to Know About the Illness Cleveland.com: Gilbert Gottfried’s myotonic dystrophy: 5 things to know about the rare genetic disorder Gilbert Gottfried’s myotonic dystrophy: 5 things to know about the rare genetic disorder FOX 10 Phoenix: What is Myotonic Dystrophy, the rare disease that reportedly contributed to Gilbert Gottfried's death? What is Myotonic Dystrophy, the rare disease that reportedly contributed to Gilbert Gottfried's death? Miami Herald: Gilbert Gottfried had myotonic dystrophy before his death. What is the rare disease?
Image Gallery
Key Insights
Comedian Gilbert Gottfried, shown in a 2016 photo, died on Tuesday, April 12, from recurrent ventricular tachycardia due to myotonic dystrophy type II. Scott Roth Scott Roth/Invision/AP Comedian ... Gilbert Gottfried had myotonic dystrophy before his death. What is the rare disease? Yahoo: What to Know About Ventricular Tachycardia and Myotonic Dystrophy, Gilbert Gottfried's 'Long Illness' What to Know About Ventricular Tachycardia and Myotonic Dystrophy, Gilbert Gottfried's 'Long Illness' Business Wire: Arrakis Therapeutics Announces Oral Presentation Describing RNA-targeted Small Molecule to Treat Myotonic Dystrophy at MDA Conference 2025 Arrakis Therapeutics Announces Oral Presentation Describing RNA-targeted Small Molecule to Treat Myotonic Dystrophy at MDA Conference 2025 Medindia on MSN: Hidden heart risks in muscular dystrophy: Why early action matters